PRNewsWire · CTXR · October 26, 2026
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: PRNewsWire ↗